Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States

Transfusion

Volumn 57, Issue 2, 2017, Pages 289-295

  Pine, Alexander B ^a   Lee, Eun Ju ^b   Sekeres, Mikkael ^e   Steensma, David P ^f   Zelterman, Daniel ^d   Prebet, Thomas ^b   DeZern, Amy ^g   Komrokji, Rami ^h   Litzow, Mark ⁱ   Luger, Selina ^j   Stone, Richard ^f   Erba, Harry P ^k   Garcia Manero, Guillermo ^l   Lee, Alfred I ^b   Podoltsev, Nikolai A ^b   Barbarotta, Lisa ^a   Kasberg, Stephanie ^a   Hendrickson, Jeanne E ^c   Gore, Steven D ^b   Zeidan, Amer M ^b  

^a Yale New Haven Hospital   (United States)

^b Department of Hematology Oncology   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; FIBRINOGEN; HEMOGLOBIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CROSS-SECTIONAL STUDY; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; HOSPITAL PATIENT; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT CARE; PROMYELOCYTIC LEUKEMIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNITED STATES; ACUTE DISEASE; BLOOD COMPONENT THERAPY; LEUKEMIA; PROTOCOL COMPLIANCE; QUESTIONNAIRE;

ACUTE DISEASE; ADULT; AGED; BLOOD COMPONENT TRANSFUSION; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; THROMBOCYTOPENIA; UNITED STATES;

EID: 85005865065     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13934     Document Type: Article

References (19)

1. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997;337:1870–5.
2. Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013;368:1771–80.
3. Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2015;162:205–13.
4. Li G, Rachmale S, Kojicic M, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011;51:338–43.
5. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757–67.
6. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44:10–5.
7. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007;21:271–89.
8. Shander A, Ozawa S, Hofmann A. Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital. Vox Sang 2016;111:55–61.
9. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409–17.
10. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453–62.
11. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11–21.
12. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015;372:997–1008.
13. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49–58.
14. Jansen AJ, Caljouw MA, Hop WC, et al. Feasibility of a restrictive red-cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia. Transfus Med 2004;14:33–8.
15. DeZern AE, Williams K, Zahurak M, et al. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study. Transfusion 2016;56:1750–7.
16. Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012;380:1309–16.
17. Kumar A, Mhaskar R, Grossman BJ, et al. Platelet transfusion: a systematic review of the clinical evidence. Transfusion 2015;55:1116–27.
18. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013;17:R76.
19. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270–382.